| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/16/2002 | US6372491 To induce vascularization |
| 04/16/2002 | US6372490 Nucleic acid encoding the MDM interacting protein |
| 04/16/2002 | US6372489 For therapy of disorders related to tyrosinase gene expression and melanin biosynthesis |
| 04/16/2002 | US6372488 AMPA-binding human GluR4 receptors |
| 04/16/2002 | US6372487 Polynucleotides encoding peptide release factor, prfC (RF-3), a GTP-binding protein |
| 04/16/2002 | US6372480 Pesticidal proteins |
| 04/16/2002 | US6372478 Vaccine vehicles are useful for administration to mammalian hosts for purposes of immunization |
| 04/16/2002 | US6372456 In diagnosis methods for detecting central nervous system and immune system-related disorders and in therapy |
| 04/16/2002 | US6372454 Also vectors, host cells; screening methods for identifying agonists or antagonists of follistatin-3 activity; diagnostic methods for detecting reproductive system and cell differentiation disorders and treating these |
| 04/16/2002 | US6372453 Neurturin receptor |
| 04/16/2002 | US6372443 Cassette for expressing a toxoplasma gondii P30 protein |
| 04/16/2002 | US6372442 Sample of body fluid is subjected to at least two distinct immunological assays, each using a different immunological binding partner, and a numerical index is formed representing the difference in results of assays |
| 04/16/2002 | US6372438 Obtaining transformed mammalian cells comprising a recombinant nucleic acid encoding a hpdgf-r polypeptide; incubating transformed mammalian cells with compound, and incubating witout compound; comparing activation in test cells |
| 04/16/2002 | US6372431 Mammalian toxicological response markers |
| 04/16/2002 | US6372424 Rapid detection and identification of pathogens |
| 04/16/2002 | US6372263 Extracted from fertilized ovum of a sea water fish or a fresh water fish |
| 04/16/2002 | US6372262 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 04/16/2002 | US6372249 Senscent cell-derived inhibitors of DNA synthesis |
| 04/16/2002 | US6372228 Method of producing elastin, elastin-based biomaterials and tropoelastin materials |
| 04/16/2002 | US6372225 Tetanus toxin functional fragment antigen and tetanus vaccine |
| 04/16/2002 | US6372224 Vaccine from isolated s protein |
| 04/16/2002 | US6372222 Antigenic group B Streptococcus type II and type III polysaccharide fragments having a 2, 5-anhydro-D-mannose terminal structure and conjugate vaccine thereof |
| 04/16/2002 | US6372219 Parasite-derived anti-inflammatory immunomodulatory protein |
| 04/16/2002 | US6372215 Monoclonal antibodies to human CD6 |
| 04/16/2002 | US6372207 IFNAR2/IFN complex |
| 04/16/2002 | US6372206 Orally-administered interferon-TAU compositions and methods |
| 04/16/2002 | CA2359650A1 Pharmaceutical preparations and methods for inhibiting tumors |
| 04/16/2002 | CA2355334A1 Pharmaceutical preparations and methods for inhibiting tumors |
| 04/16/2002 | CA2321256A1 Pharmaceutical preparations and methods for inhibiting tumours |
| 04/16/2002 | CA2217565C Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 04/16/2002 | CA2088980C Pro-drugs for cck antagonists |
| 04/16/2002 | CA2046607C Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 04/11/2002 | WO2002029418A1 Selective anxiolytic therapeutic agents |
| 04/11/2002 | WO2002029413A2 An assay for rhabdovirus inhibitors |
| 04/11/2002 | WO2002029404A1 Methods for detecting vasculopathies and tumors |
| 04/11/2002 | WO2002029403A1 Gata-3 expression inhibitor and method of screening the same |
| 04/11/2002 | WO2002029119A1 Method of detecting norwalk-like virus (gi) |
| 04/11/2002 | WO2002029105A1 INHIBITION OF TGF-β AND USES THEREOF |
| 04/11/2002 | WO2002029097A2 Methods relating to polymorphisms in the human gpr10 gene |
| 04/11/2002 | WO2002029088A2 Highly expressible genes |
| 04/11/2002 | WO2002029086A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 04/11/2002 | WO2002029084A2 Industrial-scale serum-free production of recombinant factor vii in mammalian cells |
| 04/11/2002 | WO2002029083A2 Industrial-scale serum-free production of recombinant proteins in mammalian cells |
| 04/11/2002 | WO2002029082A1 Endothelial cell mitogen bioassay |
| 04/11/2002 | WO2002029075A2 Multiple inducible gene regulation system |
| 04/11/2002 | WO2002029074A2 Genetic immunisation against cervical carcinoma |
| 04/11/2002 | WO2002029073A2 Gene delivery vectors for stem cells |
| 04/11/2002 | WO2002029072A2 Targetting molecules for adenoviral vectors |
| 04/11/2002 | WO2002029069A2 A nitrate-responsive plant root specific transcriptional factor |
| 04/11/2002 | WO2002029064A2 Method for establishing germ cell-specific gene expression |
| 04/11/2002 | WO2002029062A2 Cytokine proteins |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029060A2 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | WO2002029059A2 Nogo receptor homologs |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029056A2 Mini-dystrophin nucleic acid and peptide sequences |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029053A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/11/2002 | WO2002029052A2 Regulation of human secretin receptor-like gpcr |
| 04/11/2002 | WO2002029051A2 Human secretin receptor-like gpcr |
| 04/11/2002 | WO2002029050A2 Regulation of human secretin receptor-like gpcr |
| 04/11/2002 | WO2002029049A2 Regulation of human sodium-dependent monoamine transporter |
| 04/11/2002 | WO2002029048A2 Regulation of human sodium-dependent neurotransmitter transporter |
| 04/11/2002 | WO2002029047A2 Regulation of human gpcr-like protein |
| 04/11/2002 | WO2002029046A1 Hepatocyte nuclear factor 4-gamma: hnf4-gamma |
| 04/11/2002 | WO2002029045A2 Method for the production of vitamin k-dependent proteins |
| 04/11/2002 | WO2002029043A1 Method of identifying target gene of transcription factor and method of isolation |
| 04/11/2002 | WO2002029041A2 32146 and 57259, novel human transporters and uses thereof |
| 04/11/2002 | WO2002029039A2 47316, a novel human g-protein and uses therefor |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002029037A2 57800, a novel human cadherin and uses therefor |
| 04/11/2002 | WO2002029034A2 Exbb-exbd-tonb gene cluster of pseudomonas putida dot-t1e conferring tolerance to aromatic compounds and resistance to antibiotics |
| 04/11/2002 | WO2002029033A2 G-protein fusion receptors and chimeric gabab receptors |
| 04/11/2002 | WO2002029031A2 Isoprenoid-dependent ras anchorage (idra) proteins |
| 04/11/2002 | WO2002029030A2 Ethanol production |
| 04/11/2002 | WO2002029025A2 Factor vii glycoforms |
| 04/11/2002 | WO2002029023A1 Nicastrin protein |
| 04/11/2002 | WO2002029001A2 Novel lysophosphatidic acid receptor agonists and antagonists |
| 04/11/2002 | WO2002028999A2 Gene expression profiles in granulocytic cells |
| 04/11/2002 | WO2002028998A2 Chlamydia pmp proteins, gene sequences and uses thereof |
| 04/11/2002 | WO2002028902A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | WO2002028901A2 Seven-transmembrane (7tm) receptors and uses thereof |
| 04/11/2002 | WO2002028900A2 Tach: new tnf-receptor family nucleic acids and polypeptides |
| 04/11/2002 | WO2002028899A1 Human prostate specific g-protein receptor hpraj70 |
| 04/11/2002 | WO2002028898A2 Regulation of human secretin receptor-like gpcr |
| 04/11/2002 | WO2002028897A2 Human g-protein coupled receptor and uses thereof |
| 04/11/2002 | WO2002028896A1 Analogues of human granulocite colony stimulating factor (g-csf) |
| 04/11/2002 | WO2002028895A2 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 04/11/2002 | WO2002028894A1 Gene relating to drug tolerance and utilization thereof |
| 04/11/2002 | WO2002028893A2 Plant cyclin-dependent kinase inhibitors |
| 04/11/2002 | WO2002028892A1 Von willebrand factor-binding proteins from staphylococci |
| 04/11/2002 | WO2002028891A2 Listeria inocua, genome and applications |
| 04/11/2002 | WO2002028889A2 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/11/2002 | WO2002028888A2 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same |
| 04/11/2002 | WO2002028884A1 Site-specific protein modification |
| 04/11/2002 | WO2002028879A1 Suppressor of human breast cancer cell growth |
| 04/11/2002 | WO2002028877A1 24 human secreted proteins |
| 04/11/2002 | WO2002028873A2 Transcription factor polynucleotides, polypeptides, antibodies, and methods based thereon |
| 04/11/2002 | WO2002028437A1 Regioselective liquid phase pegylation |
| 04/11/2002 | WO2002028420A2 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |